RUBICON
Rubicon
Live Price
₹1,500.80
+9.80+0.66%
Conviction Scorecard
AI Momentum
77%Technical Rating
58%Analyst Sentiment
85%Market News & Buzz
📰
Recent news and updates for RUBICON will appear here soon.
Stockmo Analyst Rationale
AI Generated Insight
"Balanced market signals for RUBICON. The stock is currently consolidating with neutral technical indicators and fundamental alignment between current healthcare growth rates and prevailing valuation metrics."
Verified by Stockmo Intelligence Grid
Supporting Evidence
Citing cross-referenced internal documents and market technicals
About Rubicon
Rubicon Research Limited operates as a specialty pharmaceutical company in India, the United States, and internationally. Its primary proprietary technologies for drug delivery comprising RubiSRL for the formulation of sustained release liquids using a combination of ion exchange and membrane diffusion controlled-release technologies; and RubiReten, a gastro-retentive system for drugs with poor solubility and a limited window of absorption. The company develops products in the areas of analgesics/pain management, hypokalemia, gastrointestinal, cardiovascular, skeletal muscle relaxants, metabolic, central nervous system, nicotine replacement therapy, and immunosuppressant. The company was incorporated in 1999 and is based in Mumbai, India.
Frequently asked questions
As of the latest market session, Rubicon (RUBICON) is trading at ₹1,500.8, representing a move of 0.66% from the previous close.
Rubicon is listed and traded under the ticker symbol RUBICON on the National Stock Exchange of India (NSE) and Bombay Stock Exchange (BSE).
Today, Rubicon's stock price moved by 0.66%. Long-term growth trends depend on company financials, technical moving averages, and sector momentum in the Healthcare industry.
Our proprietary AI Momentum engine calculates a 77% bullish probability for RUBICON stock over the next 3-5 days. View the live interactive chart on Stockmo to see dynamic technical forecasting.
Over the past 52 weeks, Rubicon shares reached a high of ₹1,589.7 and hit a low of ₹570.75.
RUBICON exhibits standard volatility for a Healthcare stock, with an average daily trading volume of 93,505 shares. Detailed technical beta indicators are available on the Stockmo charting engine.
Rubicon has a market capitalization of ₹24777.03 Cr, designating its size class inside the Healthcare sector.
Rubicon has a current dividend yield of 10.00%. Companies may adjust payout ratios depending on quarterly earnings growth and reinvestment opportunities.
Rubicon's trailing Price-to-Earnings (P/E) ratio is 97.71. This indicates how much investors are willing to pay for every rupee of the company's annual net earnings.
You can purchase Rubicon (RUBICON) shares through any SEBI-registered stockbroker (such as Kite/Zerodha, Groww, or Angel One) by funding your trading account and executing a buy order on the NSE or BSE.
Rubicon's financial health, solvency, growth, and quality metrics are tracked using our proprietary Multibagger V2 score. You can explore RUBICON's detailed 5-tier financial scorecard and compare it with market competitors on the Stockmo Multibagger Screener page.
Institutional order blocks and pristine support/resistance triggers for RUBICON are monitored in real-time. View live technical entry levels, stop loss bounds, and target prices on our interactive Supply & Demand Trading Engine or scan entire market segments using the Basket Scanner.
Rubicon operates inside the Healthcare sector. You can analyze sector-wide trends, relative strengths, and locate top emerging leaders in this space using our Sector Analysis Hub.